

Cover Story
Guest Editorial
In May 2018, President Trump announced his plan to lower drug prices. “We will have tougher negotiation, more competition, and much lower prices at the pharmacy counter. And it will start to take effect very soon,” he promised. The plan is outlined in a 40-page document by the U.S. Department of Health and Human Services titled “American Patients First—The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Cost.” (1)
In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets


Trending Stories
- Joe Fraumeni, founder of molecular epidemiology, dies at 93
“It’s hard to imagine a world without the presence of this gentle scientific giant.” - OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Robert Mayer tells us about pancreatic cancer’s hopeless past as new data shows promise
- The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions” - What NHS-Galleri taught us—and what it didn’t
- Dana-Farber names its under-construction freestanding hospital: the Lavine Bekenstein Cancer Hospital














